Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-08

AUTHORS

Gian Paolo Fadini, Daniele Bottigliengo, Federica D’Angelo, Franco Cavalot, Antonio Carlo Bossi, Giancarlo Zatti, Ileana Baldi, Angelo Avogaro, On behalf of the DARWIN-T2D Network

ABSTRACT

INTRODUCTION: DPP-4 inhibitors (DPP4i) and sulfonylureas are popular second-line therapies for type 2 diabetes (T2D), but there is a paucity of real-world studies comparing their effectiveness in routine clinical practice. METHODS: This was a multicenter retrospective study on diabetes outpatient clinics comparing the effectiveness of DPP4i versus gliclazide extended release. The primary endpoint was change from baseline in HbA1c. Secondary endpoints were changes in fasting plasma glucose, body weight, and systolic blood pressure. Automated software extracted data from the same clinical electronic chart system at all centers. Propensity score matching (PSM) was used to generate comparable cohorts to perform outcome analysis. RESULTS: We included data on 2410 patients starting DPP4i and 1590 patients starting gliclazide (mainly 30-60 mg/day). At baseline, the two groups differed in disease duration, body weight, blood pressure, HbA1c, fasting glucose, HDL cholesterol, triglycerides, liver enzymes, eGFR, prevalence of microangiopathy, and use of metformin. Among DPP4i molecules, no difference in glycemic effectiveness was detected. In matched cohorts (n = 1316/group), patients starting DPP4i, as compared with patients starting gliclazide, experienced greater reductions in HbA1c (- 0.6% versus - 0.4%; p < 0.001), fasting glucose (- 14.1 mg/dl versus - 8.8 mg/dl; p = 0.007), and body weight (- 0.4 kg versus - 0.1 kg; p = 0.006) after an average 6 months follow-up. DPP4i improved glucose control more than gliclazide, especially in patients who had failed with other glucose-lowering medications or were on basal insulin. CONCLUSIONS: This large retrospective real-world study shows that, in routine clinical practice, starting a DPP4i allows better glycemic control than starting low-dose gliclazide. FUNDING: The Italian Diabetes Society, with external support from AstraZeneca. More... »

PAGES

1477-1490

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s13300-018-0452-y

DOI

http://dx.doi.org/10.1007/s13300-018-0452-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1104347182

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29858976


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Padua", 
          "id": "https://www.grid.ac/institutes/grid.5608.b", 
          "name": [
            "Department of Medicine, University of Padova, 35128, Padua, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fadini", 
        "givenName": "Gian Paolo", 
        "id": "sg:person.01122137075.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122137075.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Padua", 
          "id": "https://www.grid.ac/institutes/grid.5608.b", 
          "name": [
            "Department of Cardiac Thoracic and Vascular Sciences, University of Padova, 35128, Padua, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bottigliengo", 
        "givenName": "Daniele", 
        "id": "sg:person.012122301437.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012122301437.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Nazionale di Riposo e Cura per Anziani", 
          "id": "https://www.grid.ac/institutes/grid.418083.6", 
          "name": [
            "INRCA IRCSS Ancona, 60124, Ancona, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "D\u2019Angelo", 
        "givenName": "Federica", 
        "id": "sg:person.01352446266.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352446266.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ospedale San Luigi Gonzaga", 
          "id": "https://www.grid.ac/institutes/grid.415081.9", 
          "name": [
            "San Luigi Gonzaga Hospital, 10043, Orbassano, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cavalot", 
        "givenName": "Franco", 
        "id": "sg:person.0630427163.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630427163.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "ASST Bergamo Ovest, 24047, Treviglio, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bossi", 
        "givenName": "Antonio Carlo", 
        "id": "sg:person.015621125232.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015621125232.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Padua", 
          "id": "https://www.grid.ac/institutes/grid.5608.b", 
          "name": [
            "Department of Medicine, University of Padova, 35128, Padua, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zatti", 
        "givenName": "Giancarlo", 
        "id": "sg:person.013720664233.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013720664233.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Padua", 
          "id": "https://www.grid.ac/institutes/grid.5608.b", 
          "name": [
            "Department of Cardiac Thoracic and Vascular Sciences, University of Padova, 35128, Padua, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Baldi", 
        "givenName": "Ileana", 
        "id": "sg:person.01262627106.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01262627106.92"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Padua", 
          "id": "https://www.grid.ac/institutes/grid.5608.b", 
          "name": [
            "Department of Medicine, University of Padova, 35128, Padua, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Avogaro", 
        "givenName": "Angelo", 
        "id": "sg:person.01322532335.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322532335.70"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "On behalf of the DARWIN-T2D Network", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1056/nejmoa1307684", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003605360"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/biomet/70.1.41", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014390860"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1501352", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014732526"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1305889", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018262898"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc14-2441", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021071301"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.diabres.2015.07.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022111200"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.diabres.2015.07.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022111200"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.diabres.2015.05.025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027323930"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehv301", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028129316"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1479164115570301", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036826725"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1479164115570301", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036826725"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.b4731", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045927678"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehr077", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052181717"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/01621459.1996.10476908", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058305042"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/dia.2012.0272", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059249770"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-150-9-200905050-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073710774"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.25011/cim.v39i2.26481", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079252600"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1080284174", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmra1614394", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090956903"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.numecd.2017.08.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091086987"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s2213-8587(17)30317-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091687220"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/dom.13280", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101367288"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/dom.13280", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101367288"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/dom.13280", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101367288"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/9780470316696", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1109489390"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1109489390", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-08", 
    "datePublishedReg": "2018-08-01", 
    "description": "INTRODUCTION: DPP-4 inhibitors (DPP4i) and sulfonylureas are popular second-line therapies for type 2 diabetes (T2D), but there is a paucity of real-world studies comparing their effectiveness in routine clinical practice.\nMETHODS: This was a multicenter retrospective study on diabetes outpatient clinics comparing the effectiveness of DPP4i versus gliclazide extended release. The primary endpoint was change from baseline in HbA1c. Secondary endpoints were changes in fasting plasma glucose, body weight, and systolic blood pressure. Automated software extracted data from the same clinical electronic chart system at all centers. Propensity score matching (PSM) was used to generate comparable cohorts to perform outcome analysis.\nRESULTS: We included data on 2410 patients starting DPP4i and 1590 patients starting gliclazide (mainly 30-60\u00a0mg/day). At baseline, the two groups differed in disease duration, body weight, blood pressure, HbA1c, fasting glucose, HDL cholesterol, triglycerides, liver enzymes, eGFR, prevalence of microangiopathy, and use of metformin. Among DPP4i molecules, no difference in glycemic effectiveness was detected. In matched cohorts (n\u2009=\u20091316/group), patients starting DPP4i, as compared with patients starting gliclazide, experienced greater reductions in HbA1c (-\u20090.6% versus -\u20090.4%; p\u2009<\u20090.001), fasting glucose (-\u200914.1\u00a0mg/dl versus -\u20098.8\u00a0mg/dl; p\u2009=\u20090.007), and body weight (-\u20090.4\u00a0kg versus -\u20090.1\u00a0kg; p\u2009=\u20090.006) after an average 6\u00a0months follow-up. DPP4i improved glucose control more than gliclazide, especially in patients who had failed with other glucose-lowering medications or were on basal insulin.\nCONCLUSIONS: This large retrospective real-world study shows that, in routine clinical practice, starting a DPP4i allows better glycemic control than starting low-dose gliclazide.\nFUNDING: The Italian Diabetes Society, with external support from AstraZeneca.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s13300-018-0452-y", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1044057", 
        "issn": [
          "1869-6953", 
          "1869-6961"
        ], 
        "name": "Diabetes Therapy", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "9"
      }
    ], 
    "name": "Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study", 
    "pagination": "1477-1490", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "45e1b1453377e3cde2354946ab9d670287cc739c0c07f5c6fa0e8dcd82aeaf39"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29858976"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101539025"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s13300-018-0452-y"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1104347182"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s13300-018-0452-y", 
      "https://app.dimensions.ai/details/publication/pub.1104347182"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T19:21", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8678_00000604.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs13300-018-0452-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13300-018-0452-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13300-018-0452-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13300-018-0452-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13300-018-0452-y'


 

This table displays all metadata directly associated to this object as RDF triples.

195 TRIPLES      21 PREDICATES      51 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s13300-018-0452-y schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N05e94c7b6f0647d69220e8f14f29a26c
4 schema:citation https://app.dimensions.ai/details/publication/pub.1080284174
5 https://app.dimensions.ai/details/publication/pub.1109489390
6 https://doi.org/10.1002/9780470316696
7 https://doi.org/10.1016/j.diabres.2015.05.025
8 https://doi.org/10.1016/j.diabres.2015.07.002
9 https://doi.org/10.1016/j.numecd.2017.08.001
10 https://doi.org/10.1016/s2213-8587(17)30317-0
11 https://doi.org/10.1056/nejmoa1305889
12 https://doi.org/10.1056/nejmoa1307684
13 https://doi.org/10.1056/nejmoa1501352
14 https://doi.org/10.1056/nejmra1614394
15 https://doi.org/10.1080/01621459.1996.10476908
16 https://doi.org/10.1089/dia.2012.0272
17 https://doi.org/10.1093/biomet/70.1.41
18 https://doi.org/10.1093/eurheartj/ehr077
19 https://doi.org/10.1093/eurheartj/ehv301
20 https://doi.org/10.1111/dom.13280
21 https://doi.org/10.1136/bmj.b4731
22 https://doi.org/10.1177/1479164115570301
23 https://doi.org/10.2337/dc14-2441
24 https://doi.org/10.25011/cim.v39i2.26481
25 https://doi.org/10.7326/0003-4819-150-9-200905050-00006
26 schema:datePublished 2018-08
27 schema:datePublishedReg 2018-08-01
28 schema:description INTRODUCTION: DPP-4 inhibitors (DPP4i) and sulfonylureas are popular second-line therapies for type 2 diabetes (T2D), but there is a paucity of real-world studies comparing their effectiveness in routine clinical practice. METHODS: This was a multicenter retrospective study on diabetes outpatient clinics comparing the effectiveness of DPP4i versus gliclazide extended release. The primary endpoint was change from baseline in HbA1c. Secondary endpoints were changes in fasting plasma glucose, body weight, and systolic blood pressure. Automated software extracted data from the same clinical electronic chart system at all centers. Propensity score matching (PSM) was used to generate comparable cohorts to perform outcome analysis. RESULTS: We included data on 2410 patients starting DPP4i and 1590 patients starting gliclazide (mainly 30-60 mg/day). At baseline, the two groups differed in disease duration, body weight, blood pressure, HbA1c, fasting glucose, HDL cholesterol, triglycerides, liver enzymes, eGFR, prevalence of microangiopathy, and use of metformin. Among DPP4i molecules, no difference in glycemic effectiveness was detected. In matched cohorts (n = 1316/group), patients starting DPP4i, as compared with patients starting gliclazide, experienced greater reductions in HbA1c (- 0.6% versus - 0.4%; p < 0.001), fasting glucose (- 14.1 mg/dl versus - 8.8 mg/dl; p = 0.007), and body weight (- 0.4 kg versus - 0.1 kg; p = 0.006) after an average 6 months follow-up. DPP4i improved glucose control more than gliclazide, especially in patients who had failed with other glucose-lowering medications or were on basal insulin. CONCLUSIONS: This large retrospective real-world study shows that, in routine clinical practice, starting a DPP4i allows better glycemic control than starting low-dose gliclazide. FUNDING: The Italian Diabetes Society, with external support from AstraZeneca.
29 schema:genre research_article
30 schema:inLanguage en
31 schema:isAccessibleForFree true
32 schema:isPartOf N4430ec8e02874f63ae61f2ef5c9274a9
33 Nd4be2dd648dc4507aff321222a162ab4
34 sg:journal.1044057
35 schema:name Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study
36 schema:pagination 1477-1490
37 schema:productId N104da8b3529641f0aeb120be4ec9c673
38 N12956873134a48cc8ff34907e2d3efaa
39 N258859ac8bb0437cb42f3f923facc13c
40 N4632d85c4fea444d903c87c494b6fba1
41 N62f844f10b2c485c9989cf41205ef654
42 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104347182
43 https://doi.org/10.1007/s13300-018-0452-y
44 schema:sdDatePublished 2019-04-10T19:21
45 schema:sdLicense https://scigraph.springernature.com/explorer/license/
46 schema:sdPublisher N4fd0f4908adc4abbb659c46250a91557
47 schema:url https://link.springer.com/10.1007%2Fs13300-018-0452-y
48 sgo:license sg:explorer/license/
49 sgo:sdDataset articles
50 rdf:type schema:ScholarlyArticle
51 N05e94c7b6f0647d69220e8f14f29a26c rdf:first sg:person.01122137075.78
52 rdf:rest Nb80b8eda0ce146b1aa42e2fe02aba306
53 N0d50cf65bf5f403eadf64d5113358c25 rdf:first sg:person.0630427163.00
54 rdf:rest N6a1aaccf1ed54b049b9da3c8a6d316d5
55 N104da8b3529641f0aeb120be4ec9c673 schema:name nlm_unique_id
56 schema:value 101539025
57 rdf:type schema:PropertyValue
58 N12956873134a48cc8ff34907e2d3efaa schema:name doi
59 schema:value 10.1007/s13300-018-0452-y
60 rdf:type schema:PropertyValue
61 N258859ac8bb0437cb42f3f923facc13c schema:name readcube_id
62 schema:value 45e1b1453377e3cde2354946ab9d670287cc739c0c07f5c6fa0e8dcd82aeaf39
63 rdf:type schema:PropertyValue
64 N4430ec8e02874f63ae61f2ef5c9274a9 schema:volumeNumber 9
65 rdf:type schema:PublicationVolume
66 N4632d85c4fea444d903c87c494b6fba1 schema:name dimensions_id
67 schema:value pub.1104347182
68 rdf:type schema:PropertyValue
69 N4fd0f4908adc4abbb659c46250a91557 schema:name Springer Nature - SN SciGraph project
70 rdf:type schema:Organization
71 N62f844f10b2c485c9989cf41205ef654 schema:name pubmed_id
72 schema:value 29858976
73 rdf:type schema:PropertyValue
74 N6a1aaccf1ed54b049b9da3c8a6d316d5 rdf:first sg:person.015621125232.72
75 rdf:rest Nf43eaa37c5864da4b844a500d147155f
76 Na2759151f2db4a5f846bc9f8700e6d57 rdf:first sg:person.01352446266.42
77 rdf:rest N0d50cf65bf5f403eadf64d5113358c25
78 Nafeb44bbe82c4b5d80c95873975d2396 rdf:first sg:person.01322532335.70
79 rdf:rest Nfee9f6f4e1b845f2af4f8e84796ea369
80 Nb5e4d7921a254bb890067ec788bd0a83 rdf:first sg:person.01262627106.92
81 rdf:rest Nafeb44bbe82c4b5d80c95873975d2396
82 Nb80b8eda0ce146b1aa42e2fe02aba306 rdf:first sg:person.012122301437.38
83 rdf:rest Na2759151f2db4a5f846bc9f8700e6d57
84 Nc48e9c5acae64864891c1540d6229807 schema:familyName On behalf of the DARWIN-T2D Network
85 rdf:type schema:Person
86 Nd4be2dd648dc4507aff321222a162ab4 schema:issueNumber 4
87 rdf:type schema:PublicationIssue
88 Ndca383d5b7b14ffeb32004b106f0da92 schema:name ASST Bergamo Ovest, 24047, Treviglio, Italy
89 rdf:type schema:Organization
90 Nf43eaa37c5864da4b844a500d147155f rdf:first sg:person.013720664233.82
91 rdf:rest Nb5e4d7921a254bb890067ec788bd0a83
92 Nfee9f6f4e1b845f2af4f8e84796ea369 rdf:first Nc48e9c5acae64864891c1540d6229807
93 rdf:rest rdf:nil
94 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
95 schema:name Medical and Health Sciences
96 rdf:type schema:DefinedTerm
97 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
98 schema:name Clinical Sciences
99 rdf:type schema:DefinedTerm
100 sg:journal.1044057 schema:issn 1869-6953
101 1869-6961
102 schema:name Diabetes Therapy
103 rdf:type schema:Periodical
104 sg:person.01122137075.78 schema:affiliation https://www.grid.ac/institutes/grid.5608.b
105 schema:familyName Fadini
106 schema:givenName Gian Paolo
107 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122137075.78
108 rdf:type schema:Person
109 sg:person.012122301437.38 schema:affiliation https://www.grid.ac/institutes/grid.5608.b
110 schema:familyName Bottigliengo
111 schema:givenName Daniele
112 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012122301437.38
113 rdf:type schema:Person
114 sg:person.01262627106.92 schema:affiliation https://www.grid.ac/institutes/grid.5608.b
115 schema:familyName Baldi
116 schema:givenName Ileana
117 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01262627106.92
118 rdf:type schema:Person
119 sg:person.01322532335.70 schema:affiliation https://www.grid.ac/institutes/grid.5608.b
120 schema:familyName Avogaro
121 schema:givenName Angelo
122 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322532335.70
123 rdf:type schema:Person
124 sg:person.01352446266.42 schema:affiliation https://www.grid.ac/institutes/grid.418083.6
125 schema:familyName D’Angelo
126 schema:givenName Federica
127 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352446266.42
128 rdf:type schema:Person
129 sg:person.013720664233.82 schema:affiliation https://www.grid.ac/institutes/grid.5608.b
130 schema:familyName Zatti
131 schema:givenName Giancarlo
132 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013720664233.82
133 rdf:type schema:Person
134 sg:person.015621125232.72 schema:affiliation Ndca383d5b7b14ffeb32004b106f0da92
135 schema:familyName Bossi
136 schema:givenName Antonio Carlo
137 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015621125232.72
138 rdf:type schema:Person
139 sg:person.0630427163.00 schema:affiliation https://www.grid.ac/institutes/grid.415081.9
140 schema:familyName Cavalot
141 schema:givenName Franco
142 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630427163.00
143 rdf:type schema:Person
144 https://app.dimensions.ai/details/publication/pub.1080284174 schema:CreativeWork
145 https://app.dimensions.ai/details/publication/pub.1109489390 schema:CreativeWork
146 https://doi.org/10.1002/9780470316696 schema:sameAs https://app.dimensions.ai/details/publication/pub.1109489390
147 rdf:type schema:CreativeWork
148 https://doi.org/10.1016/j.diabres.2015.05.025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027323930
149 rdf:type schema:CreativeWork
150 https://doi.org/10.1016/j.diabres.2015.07.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022111200
151 rdf:type schema:CreativeWork
152 https://doi.org/10.1016/j.numecd.2017.08.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091086987
153 rdf:type schema:CreativeWork
154 https://doi.org/10.1016/s2213-8587(17)30317-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091687220
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1056/nejmoa1305889 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018262898
157 rdf:type schema:CreativeWork
158 https://doi.org/10.1056/nejmoa1307684 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003605360
159 rdf:type schema:CreativeWork
160 https://doi.org/10.1056/nejmoa1501352 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014732526
161 rdf:type schema:CreativeWork
162 https://doi.org/10.1056/nejmra1614394 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090956903
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1080/01621459.1996.10476908 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058305042
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1089/dia.2012.0272 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059249770
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1093/biomet/70.1.41 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014390860
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1093/eurheartj/ehr077 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052181717
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1093/eurheartj/ehv301 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028129316
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1111/dom.13280 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101367288
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1136/bmj.b4731 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045927678
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1177/1479164115570301 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036826725
179 rdf:type schema:CreativeWork
180 https://doi.org/10.2337/dc14-2441 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021071301
181 rdf:type schema:CreativeWork
182 https://doi.org/10.25011/cim.v39i2.26481 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079252600
183 rdf:type schema:CreativeWork
184 https://doi.org/10.7326/0003-4819-150-9-200905050-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073710774
185 rdf:type schema:CreativeWork
186 https://www.grid.ac/institutes/grid.415081.9 schema:alternateName Ospedale San Luigi Gonzaga
187 schema:name San Luigi Gonzaga Hospital, 10043, Orbassano, Italy
188 rdf:type schema:Organization
189 https://www.grid.ac/institutes/grid.418083.6 schema:alternateName Istituto Nazionale di Riposo e Cura per Anziani
190 schema:name INRCA IRCSS Ancona, 60124, Ancona, Italy
191 rdf:type schema:Organization
192 https://www.grid.ac/institutes/grid.5608.b schema:alternateName University of Padua
193 schema:name Department of Cardiac Thoracic and Vascular Sciences, University of Padova, 35128, Padua, Italy
194 Department of Medicine, University of Padova, 35128, Padua, Italy
195 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...